Loading...

Newstrike Brands

BST:0N8
Snowflake Description

Excellent balance sheet with weak fundamentals.

The Snowflake is generated from 30 checks in 5 different areas, read more below.
0N8
BST
CA$278M
Market Cap
  1. Home
  2. DE
  3. Pharmaceuticals & Biotech
Company description

Newstrike Brands Ltd., together with its subsidiaries, produces and sells medical marijuana in Canada. The last earnings update was 87 days ago. More info.


Add to Portfolio Compare Print
0N8 Share Price and Events
7 Day Returns
0%
BST:0N8
6.1%
DE Pharmaceuticals
4.2%
DE Market
1 Year Returns
-
BST:0N8
-22.3%
DE Pharmaceuticals
-9.9%
DE Market
0N8 Shareholder Return
  7 Day 30 Day 90 Day 1 Year 3 Year 5 Year
Newstrike Brands (0N8) 0% 0% 3.2% - - -
DE Pharmaceuticals 6.1% -1.8% -14.1% -22.3% -16.7% 29.4%
DE Market 4.2% -4.1% -6.7% -9.9% 25.7% 52.5%
1 Year Return vs Industry and Market
  • No trading data on 0N8.
  • No trading data on 0N8.
Price Volatility
Industry
5yr Volatility vs Market

0N8 Value

 Is Newstrike Brands undervalued based on future cash flows and its price relative to the stock market?

Value is all about what a company is worth versus what price it is available for. If you went into a grocery store and all the bananas were on sale at half price, they could be considered undervalued.
INTRINSIC VALUE BASED ON FUTURE CASH FLOWS
  • It is not possible to calculate the future cash flow value for Newstrike Brands. This is due to cash flow or dividend data being unavailable. The share price is €0.319.
PRICE RELATIVE TO MARKET
We can also value a company based on what the stock market is willing to pay for it. This is similar to the price of fruit (e.g. Mangoes or Avocados) increasing when they are out of season, or how much your home is worth.

The amount the stock market is willing to pay for Newstrike Brands's earnings, growth and assets is considered below, and whether this is a fair price.
Price based on past earnings
Are Newstrike Brands's earnings available for a low price, and how does this compare to other companies in the same industry?
Raw Data
BST:0N8 PE (Price to Earnings) Ratio Data Sources
Data Point Source Value
Earnings Per Share * Company Filings (2018-06-30) in CAD CA$-0.02
TSXV:HIP Share Price ** TSXV (2018-08-07) in CAD CA$0.5
Germany Pharmaceuticals Industry PE Ratio Median Figure of 6 Publicly-Listed Pharmaceuticals Companies 18.03x
Germany Market PE Ratio Median Figure of 411 Publicly-Listed Companies 18.08x

* Trailing twelve months (TTM) annual GAAP earnings per share excluding extraordinary items.

** Primary Listing of Newstrike Brands.

BST:0N8 PE (Price to Earnings) Ratio Calculation
Calculation Outcome
PE Ratio

= TSXV:HIP Share Price ÷ EPS (both in CAD)

= 0.5 ÷ -0.02

-20.5x

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Newstrike Brands is loss making, we can't compare its value to the DE Pharmaceuticals industry average.
  • Newstrike Brands is loss making, we can't compare the value of its earnings to the Germany market.
Price based on expected Growth
Does Newstrike Brands's expected growth come at a high price?
Raw Data
BST:0N8 PEG (Price to Earnings to Growth) Ratio Data Sources
Data Point Source Value
PE Ratio See PE Ratio Section -20.5x
Net Income Annual Growth Rate See Future Growth Section.
Line of Best Fit* through Consensus Estimate Earnings of 0 Analysts
Not available
Germany Pharmaceuticals Industry PEG Ratio Median Figure of 5 Publicly-Listed Pharmaceuticals Companies 1.42x
Germany Market PEG Ratio Median Figure of 272 Publicly-Listed Companies 1.4x

*Line of best fit is calculated by linear regression .

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Unable to calculate PEG ratio for Newstrike Brands, we can't assess if its growth is good value.
Price based on value of assets
What value do investors place on Newstrike Brands's assets?
Raw Data
BST:0N8 PB (Price to Book) Ratio Data Sources
Data Point Source Value
Book Value per Share Company Filings (2018-06-30) in CAD CA$0.29
TSXV:HIP Share Price * TSXV (2018-08-07) in CAD CA$0.5
Germany Pharmaceuticals Industry PB Ratio Median Figure of 9 Publicly-Listed Pharmaceuticals Companies 1.71x
Germany Market PB Ratio Median Figure of 549 Publicly-Listed Companies 1.88x
BST:0N8 PB (Price to Book) Ratio Calculation
Calculation Outcome
PB Ratio

= TSXV:HIP Share Price ÷ Book Value per Share (both in CAD)

= 0.5 ÷ 0.29

1.75x

* Primary Listing of Newstrike Brands.

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Newstrike Brands is overvalued based on assets compared to the DE Pharmaceuticals industry average.
X
Value checks
We assess Newstrike Brands's value by looking at:
  1. Is the discounted cash flow value less than 20%, or 40% of the share price? (2 checks) ( Click here or on bar chart for details of DCF calculation. )
  2. Is the PE ratio less than the market average, and/ or less than the Pharmaceuticals industry average (and greater than 0)? (2 checks)
  3. Is the PEG ratio within a reasonable range (0 to 1)? (1 check)
  4. Is the PB ratio less than the Pharmaceuticals industry average (and greater than 0)? (1 check)
  5. Newstrike Brands has a total score of 0/6, see the detailed checks below.

    Note: We use GAAP Earnings per Share in all our calculations including PE and PEG Ratio.

    Full details on the Value part of the Simply Wall St company analysis model.

0N8 Future Performance

 How is Newstrike Brands expected to perform in the next 1 to 3 years based on estimates from 0 analysts?

In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Newstrike Brands has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by Simply Wall St do have past financial data. You can see them here.

Show me the analysis anyway

The future performance of a company is measured in the same way as past performance, by looking at estimated growth and how much profit it is expected to make.

Future estimates come from professional analysts. Just like forecasting the weather, they don’t always get it right!
Annual Growth Rate
12.6%
Expected Pharmaceuticals industry annual growth in earnings.
Earnings growth vs Low Risk Savings
Is Newstrike Brands expected to grow at an attractive rate?
  • Unable to compare Newstrike Brands's earnings growth to the low risk savings rate as no estimate data is available.
Growth vs Market Checks
  • Unable to compare Newstrike Brands's earnings growth to the Germany market average as no estimate data is available.
  • Unable to compare Newstrike Brands's revenue growth to the Germany market average as no estimate data is available.
Annual Growth Rates Comparison
Raw Data
BST:0N8 Future Growth Rates Data Sources
Data Point Source Value (per year)
Germany Pharmaceuticals Industry Earnings Growth Rate Market Cap Weighted Average 12.6%
Germany Pharmaceuticals Industry Revenue Growth Rate Market Cap Weighted Average 5.6%
Germany Market Earnings Growth Rate Market Cap Weighted Average 10.8%
Germany Market Revenue Growth Rate Market Cap Weighted Average 5.3%

*Line of best fit is calculated by linear regression .

Industry and Market average data is calculated daily.

Learn more about our growth rate calculations in Simply Wall St’s analysis model.

Analysts growth expectations
Raw Data
BST:0N8 Analysts Growth Expectations Data Sources
Data Point Source Value
Past Financials Company Filings (4 months ago) See Below
Future Estimates Average of up to 0 Analyst Estimates (S&P Global) See Below
All numbers in CAD Millions and using Trailing twelve months (TTM) annual period rather than quarterly.
BST:0N8 Past Financials Data
Date (Data in CAD Millions) Revenue Cash Flow Net Income *
2018-06-30 -7 -11
2018-03-31 -2 -10
2017-12-31 -7 -14
2017-09-30 -2 -14
2016-12-31 -1 -1
2015-12-31 -0 -0

*GAAP earnings excluding extraordinary items.

Super high growth metrics
High Growth Checks
  • Unable to determine if Newstrike Brands is high growth as no earnings estimate data is available.
  • Unable to determine if Newstrike Brands is high growth as no revenue estimate data is available.
Past and Future Earnings per Share
The accuracy of the analysts who estimate the future performance data can be gauged below. We look back 3 years and see if they were any good at predicting what actually occurred. We also show the highest and lowest estimates looking forward to see if there is a wide range.
Raw Data
BST:0N8 Past and Future Earnings per Share
Data Point Source Value
Past Financials Company Filings (4 months ago) See Below
Future Estimates Average of up to 0 Analyst Estimates (S&P Global) See Below

All data from Newstrike Brands Company Filings, last reported 4 months ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

BST:0N8 Past Financials Data
Date (Data in CAD Millions) EPS *
2018-06-30 -0.02
2018-03-31 -0.03
2017-12-31 -0.06
2017-09-30 -0.10
2016-12-31 -0.03
2015-12-31 -0.02

*GAAP earnings excluding extraordinary items.

Performance in 3 years
In the same way as past performance we look at the future estimated return (profit) compared to the available funds. We do this looking forward 3 years.
  • Unable to establish if Newstrike Brands will efficiently use shareholders’ funds in the future without estimates of Return on Equity.

Next steps:

  1. Examine Newstrike Brands's financial health to determine how well-positioned it is against times of financial stress by looking at its level of debt over time and how much cash it has left.
  2. Newstrike Brands's future outlook can be gauged by looking at industry trends and market size, and determining how well-positioned the company is compared to its competitors. Take a look at other high-growth Pharmaceuticals & Biotech companies here
  3. Newstrike Brands's competitive advantages and company strategy can generally be found in its financial reports archived here.
  4. Use fundamentals to screen for another stock to analyse from our database of over 75,000 companies worldwide
X
Future performance checks
We assess Newstrike Brands's future performance by looking at:
  1. Is the annual earnings growth rate expected to beat the low risk savings rate, plus a premium to keep pace with inflation?
  2. Is the annual earnings growth rate expected to beat the average growth rate in earnings of the Germany market? (1 check)
  3. Is the annual revenue growth rate expected to beat the average growth rate in revenue of the Germany market? (1 check)
  4. Is the annual earnings growth rate expected to be above 20%? (1 check)
  5. Is the annual revenue growth rate expected to be above 20%? (1 check)
  6. Is the Return on Equity in 3 years expected to be over 20%? (1 check)
Some of the above checks will fail if the company is expected to be loss making in the relevant year.
Newstrike Brands has a total score of 0/6, see the detailed checks below.

Note 1: We use GAAP Net Income Excluding Exceptional Items for our Earnings in all our calculations.

Full details on the Future part of the Simply Wall St company analysis model.

0N8 Past Performance

  How has Newstrike Brands performed over the past 5 years?

The past performance of a company can be measured by how much growth it has experienced and how much profit it makes relative to the funds and assets it has available.
Past earnings growth
Below we compare Newstrike Brands's growth in the last year to its industry (Pharmaceuticals).
Past Earnings growth analysis
We also check if the company has grown in the past 5 years, and whether it has maintained that growth in the year.
  • Newstrike Brands does not make a profit and there is insufficient past data to establish if their 5 year on year earnings growth rate was positive.
  • Unable to compare Newstrike Brands's 1-year earnings growth to the 5-year average as it is not currently profitable.
  • Unable to compare Newstrike Brands's 1-year growth to the DE Pharmaceuticals industry average as it is not currently profitable.
Earnings and Revenue History
Newstrike Brands's revenue and profit over the past 5 years is shown below, any years where they have experienced a loss will show up in red.
Raw Data

All data from Newstrike Brands Company Filings, last reported 4 months ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

BST:0N8 Past Revenue, Cash Flow and Net Income Data
Date (Data in CAD Millions) Revenue Net Income * G+A Expenses R&D Expenses
2018-06-30 -10.55 22.73
2018-03-31 -10.27 13.79
2017-12-31 -14.09 7.93
2017-09-30 -14.06 5.78
2016-12-31 -0.86 0.42
2015-12-31 -0.24 0.15

*GAAP earnings excluding extraordinary items.

Performance last year
We want to ensure a company is making the most of what it has available. This is done by comparing the return (profit) to a company's available funds, assets and capital.
  • It is difficult to establish if Newstrike Brands has efficiently used shareholders’ funds last year (Return on Equity greater than 20%) as it is loss-making.
  • It is difficult to establish if Newstrike Brands has efficiently used its assets last year compared to the DE Pharmaceuticals industry average (Return on Assets) as it is loss-making.
  • It is difficult to establish if Newstrike Brands improved its use of capital last year versus 3 years ago (Return on Capital Employed) as it is currently loss-making.
X
Past performance checks
We assess Newstrike Brands's performance over the past 5 years by checking for:
  1. Has earnings increased in past 5 years? (1 check)
  2. Has the earnings growth in the last year exceeded that of the Pharmaceuticals industry? (1 check)
  3. Is the recent earnings growth over the last year higher than the average annual growth over the past 5 years? (1 check)
  4. Is the Return on Equity (ROE) higher than 20%? (1 check)
  5. Is the Return on Assets (ROA) above industry average? (1 check)
  6. Has the Return on Capital Employed (ROCE) increased from 3 years ago? (1 check)
The above checks will fail if the company has reported a loss in the most recent earnings report. Some checks require at least 3 or 5 years worth of data.
Newstrike Brands has a total score of 0/6, see the detailed checks below.

Note: We use GAAP Net Income excluding extraordinary items in all our calculations.

Full details on the Past part of the Simply Wall St company analysis model.

0N8 Health

 How is Newstrike Brands's financial health and their level of debt?

A company's financial position is much like your own financial position, it includes everything you own (assets) and owe (liabilities).

The boxes below represent the relative size of what makes up Newstrike Brands's finances.

The net worth of a company is the difference between its assets and liabilities.
Net Worth
  • Newstrike Brands is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.
  • Newstrike Brands's cash and other short term assets cover its long term commitments.
Balance sheet
This treemap shows a more detailed breakdown of Newstrike Brands's finances. If any of them are yellow this indicates they may be out of proportion and red means they relate to one of the checks below.
Assets
Liabilities and shares
The 'shares' portion represents any funds contributed by the owners (shareholders) and any profits.
  • Low level of unsold assets.
  • Debt is covered by short term assets, assets are 157.5x debt.
Historical Debt
Nearly all companies have debt. Debt in itself isn’t bad, however if the debt is too high, or the company can’t afford to pay the interest on its debts this may have impacts in the future.

The graphic below shows equity (available funds) and debt, we ideally want to see the red area (debt) decreasing.

If there is any debt we look at the companies capability to repay it, and whether the level has increased over the past 5 years.
Raw Data

All data from Newstrike Brands Company Filings, last reported 4 months ago.

BST:0N8 Past Debt and Equity Data
Date (Data in CAD Millions) Total Equity Total Debt Cash & Short Term Investments
2018-06-30 157.50 0.88 125.47
2018-03-31 113.93 0.90 88.45
2017-12-31 12.58 9.32 0.81
2017-09-30 12.98 9.23 5.06
2016-12-31 0.85 1.31 0.08
2015-12-31 0.10 0.16 0.00
  • Newstrike Brands's level of debt (0.6%) compared to net worth is satisfactory (less than 40%).
  • Unable to establish if Newstrike Brands's debt level has increased without past 5-year debt data.
CASH RUNWAY ANALYSIS

For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.

  • Newstrike Brands has sufficient cash runway for more than 3 years based on current free cash flow.
  • Newstrike Brands has sufficient cash runway for more than 3 years if free cash flow continues to grow at historical rates of 124.2% each year.
X
Financial health checks
We assess Newstrike Brands's financial health by checking for:
  1. Are short term assets greater than short term liabilities? (1 check)
  2. Are short term assets greater than long term liabilities? (1 check)
  3. Has the debt to equity ratio increased in the past 5 years? (1 check)
  4. Is the debt to equity ratio over 40%? (1 check)
  5. Is the debt covered by operating cash flow? (1 check)
  6. Are earnings greater than 5x the interest on debt (if company pays interest at all)? (1 check)
  7. Newstrike Brands has a total score of 5/6, see the detailed checks below.
For companies that are loss making and have been so on average in the past we replace the last 2 checks with:
  1. Does cash and short term investments cover stable operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)
  2. Does cash and short term investments cover growing operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)


Full details on the Health part of the Simply Wall St company analysis model.

0N8 Dividends

 What is Newstrike Brands's current dividend yield, its reliability and sustainability?

Dividends are regular cash payments to you from the company, similar to a bank paying you interest on a savings account.
Annual Dividend Income
Dividend payments
0%
Current annual income from Newstrike Brands dividends.
If you bought €2,000 of Newstrike Brands shares you are expected to receive €0 in your first year as a dividend.
Dividend Amount
Here we look how much dividend is being paid, if any. Is it above what you can get in a savings account? It is up there with the best dividend paying companies?
  • Unable to evaluate Newstrike Brands's dividend yield against the bottom 25% of dividend payers as the company has not reported any payouts.
  • Unable to evaluate Newstrike Brands's dividend against the top 25% market benchmark as the company has not reported any payouts.
Annualized Historical and Future Dividends
It is important to see if the dividend for a company is stable, and not wildly increasing/decreasing each year. This graph shows you the historical rate to count toward your assessment of the stock.

We also check to see if the dividend has increased in the past 10 years.
Raw Data
BST:0N8 Annualized Past and Future Dividends
Data Point Source Value
Past Annualized Dividend Yield S&P Global Market Data See Below
Past Dividends per Share Company Filings/ Annualized Dividend Payments See Below
Future Dividends per Share Estimates Average of up to 0 Analyst Estimates (S&P Global) See Below
Europe Pharmaceuticals Industry Average Dividend Yield Market Cap Weighted Average of 31 Stocks 3.4%
Germany Market Average Dividend Yield Market Cap Weighted Average of 323 Stocks 3%
Germany Minimum Threshold Dividend Yield 10th Percentile 0.9%
Germany Bottom 25% Dividend Yield 25th Percentile 1.5%
Germany Top 25% Dividend Yield 75th Percentile 3.8%

Industry and Market average data is calculated daily.

Note all dividend per share amounts are annualized and not quarterly or other period.

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Unable to perform a dividend volatility check as Newstrike Brands has not reported any payouts.
  • Unable to verify if Newstrike Brands's dividend has been increasing as the company has not reported any payouts.
Current Payout to shareholders
What portion of Newstrike Brands's earnings are paid to the shareholders as a dividend.
  • Unable to calculate sustainability of dividends as Newstrike Brands has not reported any payouts.
Future Payout to shareholders
  • Insufficient estimate data to determine if a dividend will be paid in 3 years and that it will be sustainable.
X
Income/ dividend checks
We assess Newstrike Brands's dividend by checking for:
  1. Firstly is the company paying a notable dividend (greater than 0.9%) - if not then the rest of the checks are ignored.
  2. Is current dividend yield above the bottom 25% of dividend payers? (1 check)
  3. Is current dividend yield above the top 25% of dividend payers? (1 check)
  4. Have they paid a dividend for 10 years, and during this period has the dividend been volatile (drop of more than 25%)? (1 check)
  5. If they have paid a dividend for 10 years has it increased in this time? (1 check)
  6. How sustainable is the dividend, can Newstrike Brands afford to pay it from its earnings today and in 3 years (Payout ratio less than 90%)? (2 checks)
  7. Newstrike Brands has a total score of 0/6, see the detailed checks below.


Full details on the Dividends part of the Simply Wall St company analysis model.

0N8 Management

 What is the CEO of Newstrike Brands's salary, the management and board of directors tenure and is there insider trading?

Management is one of the most important areas of a company. We look at unreasonable CEO compensation, how long the team and board of directors have been around for and insider trading.
CEO
Jay Wilgar
AGE 43
TENURE AS CEO 1.8 years
CEO Bio

Mr. James Wilgar, also known as Jay, has been Chief Executive Officer and Director of Newstrike Resources Ltd. since 2017 and also serves as its President since May 29, 2017. Mr. Wilgar founded HPI Holdings Ltd. in 2013 and served as its Chief Executive Officer from 2013 to May 2017. He served as Vice President of Business Development at Engie (Canada) Inc. (formerly GDF Suez Canada Inc.) from 2010 to 2014. Mr. Wilgar co-founded GDF SUEZ Canada, Inc. and served as its Vice President of Field Operations. Within GDF SUEZ Canada, Inc., he headed up land acquisition and project financial modelling. He Co-Founded EnWise Holdings Inc. in September 2006 and served as its Secretary. He was the Founder of AIM PowerGen Corporation in 2001 (Sold to International Power Canada, a subsidiary of GDF Suez (now Engie) in 2009) and served as its Chief Executive Officer. He has been Chairman of Newstrike Resources Ltd. since May 22, 2018. He served as a Partner of Pentagon Capital Partners Inc., an asset based financing company. His career has spanned investor relations and several entrepreneurial ventures. He serves as Director of HPI Holdings Ltd. Mr. Wilgar serves as Director of GDF SUEZ Canada, Inc. and EnWise Holdings Inc. Mr. Wilgar has often spoken to student groups on small business development and served as a judge of the Nestle Reach for Your Dreams entrepreneurship challenge. Mr. Wilgar holds a Bachelor of Commerce degree from Wilfrid Laurier University.

CEO Compensation
  • Insufficient data for Jay to compare compensation growth.
  • Insufficient data for Jay to establish whether their remuneration is reasonable compared to companies of similar size in Germany.
Management Team Tenure

Average tenure and age of the Newstrike Brands management team in years:

1.7
Average Tenure
44
Average Age
  • The average tenure for the Newstrike Brands management team is less than 2 years, this suggests a new team.
Management Team

Jay Wilgar

TITLE
Chairman
AGE
43
TENURE
1.8 yrs

Jason Redman

TITLE
Chief Financial Officer
TENURE
0.5 yrs

Kevin Epp

TITLE
Chief Operating Officer
AGE
49
TENURE
1.5 yrs

Peter Hwang

TITLE
Chief Commercial Officer & Director
AGE
44
TENURE
0.3 yrs

Jennifer Maccarone

TITLE
Chief Quality Officer and VP of Quality Control
AGE
33
TENURE
1.8 yrs

Jonathan Wolch

TITLE
Corporate Secretary
AGE
52
TENURE
1.8 yrs
Board of Directors Tenure

Average tenure and age of the Newstrike Brands board of directors in years:

1.3
Average Tenure
45.5
Average Age
  • The average tenure for the Newstrike Brands board of directors is less than 3 years, this suggests a new board.
Board of Directors

Peter Hwang

TITLE
Chief Commercial Officer & Director
AGE
44
TENURE
1.8 yrs

Niklas Van Haeren

TITLE
Director
AGE
38
TENURE
1.8 yrs

Jay Wilgar

TITLE
Chairman
AGE
43
TENURE
0.5 yrs

Steve Smith

TITLE
Lead Director
AGE
61

Liam Scott

TITLE
Director
AGE
47
TENURE
1.8 yrs

Christopher Andrews

TITLE
Member of Advisory Board
TENURE
1.3 yrs

Bernie Breen

TITLE
Member of Advisory Board
TENURE
1.3 yrs

Joan Chypyha

TITLE
Member of Advisory Board
TENURE
1.3 yrs

Jeff Craib

TITLE
Member of Advisory Board
AGE
52
TENURE
1.3 yrs

Mike Egli

TITLE
Member of Advisory Board
TENURE
1.3 yrs
Who owns this company?
Recent Insider Trading
  • No 3 month insider trading information.
Recent Insider Transactions
Announced Type Name Entity Start End Shares Max Price (CAD) Value (CAD)
26. Sep 18 Sell Travis Kanellos Individual 18. Sep 18 18. Sep 18 -2,000 CA$0.57 CA$-1,145.90
17. Sep 18 Sell Travis Kanellos Individual 12. Sep 18 13. Sep 18 -258,500 CA$0.58 CA$-144,500.63
31. Aug 18 Sell Travis Kanellos Individual 27. Aug 18 27. Aug 18 -16,500 CA$0.53 CA$-8,820.44
30. Aug 18 Sell John Morgan Individual 17. Aug 18 17. Aug 18 -160,000 CA$0.35 CA$-54,806.44
28. Jun 18 Sell John Morgan Individual 12. Jun 18 12. Jun 18 -350,000 CA$0.46 CA$-159,991.42
20. Jun 18 Buy Niklas Van Haeren Individual 19. Jun 18 19. Jun 18 16,400 CA$0.42 CA$6,937.26
23. Apr 18 Sell Travis Kanellos Individual 18. Apr 18 20. Apr 18 -212,000 CA$0.67 CA$-139,261.44
18. Apr 18 Sell Travis Kanellos Individual 16. Mar 18 16. Mar 18 -100,000 CA$0.74 CA$-73,433.48
18. Apr 18 Sell Travis Kanellos Individual 05. Apr 18 17. Apr 18 -599,000 CA$0.70 CA$-396,557.72
29. Mar 18 Sell Jonathan Wolch Individual 29. Mar 18 29. Mar 18 -5,000 CA$0.71 CA$-3,560.61
28. Mar 18 Sell Jonathan Wolch Individual 28. Mar 18 28. Mar 18 -15,000 CA$0.66 CA$-9,903.52
06. Dec 17 Sell Niklas Van Haeren Individual 22. Nov 17 22. Nov 17 -400,000 CA$0.14 CA$-55,969.54
06. Dec 17 Buy Niklas Van Haeren Individual 06. Jun 17 07. Jul 17 330,010 CA$0.22 CA$69,133.26
X
Management checks
We assess Newstrike Brands's management by checking for:
  1. Is the CEO's compensation unreasonable compared to market cap? (1 check)
  2. Has the CEO's compensation increased more than 20% whilst the EPS is down more then 20%? (1 check)
  3. Is the average tenure of the management team less than 2 years? (1 check)
  4. Is the average tenure of the board of directors team less than 3 years? (1 check)
  5. Newstrike Brands has a total score of 0/6, this is not included on the snowflake, see the detailed checks below.


Note: We use the top 6 management executives and board members in our calculations.

Note 2: Insider trading include any internal stakeholders and these transactions .

Full details on the Management part of the Simply Wall St company analysis model.

0N8 News

External News
Loading...
Simply Wall St News

0N8 Company Info

Map
Description

Newstrike Brands Ltd., together with its subsidiaries, produces and sells medical marijuana in Canada. It offers cannabis in various forms, such as dried and fresh marijuana. The company is headquartered in Toronto, Canada.

Details
Name: Newstrike Brands Ltd.
0N8
Exchange: BST
Founded:
CA$186,416,291
556,596,090
Website: http://www.newstrike.ca
Address: Newstrike Brands Ltd.
390 Bay Street,
Suite 612,
Toronto,
Ontario, M5H 2Y2,
Canada
Listings
Exchange Symbol Ticker Symbol Security Exchange Country Currency Listed on
TSXV HIP New Common Shares TSX Venture Exchange CA CAD 30. May 2017
OTCPK NWKR.F New Common Shares Pink Sheets LLC US USD 30. May 2017
DB 0N8 New Common Shares Deutsche Boerse AG DE EUR 30. May 2017
BST 0N8 New Common Shares Boerse-Stuttgart DE EUR 30. May 2017
Number of employees
Current staff
Staff numbers
71
Newstrike Brands employees.
Industry
Pharmaceuticals
Pharmaceuticals & Biotech
Company Analysis and Financial Data Status
Area Date (UTC time)
Company Analysis updated: 2018/11/04 18:50
End of day share price update: 2018/08/07 00:00
Last earnings filing: 2018/08/09
Last earnings reported: 2018/06/30
Last annual earnings reported: 2017/12/31


All dates and times in UTC. All financial data provided by Standard & Poor’s Capital IQ.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.